A relatively small number of participants with abnormal eGFR values prevented us from examining associations between plasma tau biomarkers and kidney dysfunction in CKD+ and CKD− groups separately, something that should be explored in future studies. This evidence concerns the gene MAPT and chronic kidney disease.